- Home
- STRO vs IOR Comparison
STRO vs IOR Comparison
Compare STRO & IOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- IOR
- Stock Information
- Founded
- STRO 2003
- IOR 1984
- Country
- STRO United States
- IOR United States
- Employees
- STRO N/A
- IOR N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- IOR Real Estate Investment Trusts
- Sector
- STRO Health Care
- IOR Real Estate
- Exchange
- STRO Nasdaq
- IOR Nasdaq
- Market Cap
- STRO 69.1M
- IOR 72.8M
- IPO Year
- STRO 2018
- IOR N/A
- Fundamental
- Price
- STRO $0.97
- IOR $18.20
- Analyst Decision
- STRO Hold
- IOR
- Analyst Count
- STRO 7
- IOR 0
- Target Price
- STRO $1.97
- IOR N/A
- AVG Volume (30 Days)
- STRO 553.4K
- IOR 180.0
- Earning Date
- STRO 08-07-2025
- IOR 11-06-2025
- Dividend Yield
- STRO N/A
- IOR N/A
- EPS Growth
- STRO N/A
- IOR N/A
- EPS
- STRO N/A
- IOR 1.06
- Revenue
- STRO $104,473,000.00
- IOR N/A
- Revenue This Year
- STRO $65.42
- IOR N/A
- Revenue Next Year
- STRO N/A
- IOR N/A
- P/E Ratio
- STRO N/A
- IOR $17.24
- Revenue Growth
- STRO N/A
- IOR N/A
- 52 Week Low
- STRO $0.52
- IOR $16.01
- 52 Week High
- STRO $4.80
- IOR $19.69
- Technical
- Relative Strength Index (RSI)
- STRO 58.41
- IOR 33.70
- Support Level
- STRO $0.90
- IOR $18.01
- Resistance Level
- STRO $1.18
- IOR $18.89
- Average True Range (ATR)
- STRO 0.09
- IOR 0.02
- MACD
- STRO 0.01
- IOR -0.01
- Stochastic Oscillator
- STRO 43.43
- IOR 59.38
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About IOR Income Opportunity Realty Investors Inc.
Income Opportunity Realty Investors Inc is a U.S.-based company that is an externally managed company that invests in mortgage notes receivables and real property. The business of the company is managed by Pillar Income Asset Management, Inc. The company's activities include locating, evaluating and recommending investment opportunities. Pillar also arranges its debt and equity financing with unaffiliated independent third party lenders and investors.